AIMC Topic: Ifosfamide

Clear Filters Showing 1 to 2 of 2 articles

Long-term benefit from high-dose ifosfamide in sarcoma depends on sustained prior control and timely intervention: a machine learning analysis.

Journal of cancer research and clinical oncology Jan 8, 2026
PURPOSE: High-dose ifosfamide (HD-IFO) remains an effective regimen for advanced bone and soft tissue sarcomas, but predictors of long-term benefit are poorly defined. This study evaluated clinical outcomes and prognostic factors using machine learni...
Humans Machine Learning Prognosis Retrospective Studies Female Aged Young Adult Adult Male Middle Aged Adolescent Bone Neoplasms Sarcoma Ifosfamide Antineoplastic Agents, Alkylating
View on PubMed DOI

[RETROPERITONEAL LIPOSARCOMA WITH MULTIPLE RECURRENCE OF LUNG METASTASES TREATED BY MULTIMODAL THERAPY CENTERING ON THE OPERATION: A CASE REPORT].

Nihon Hinyokika Gakkai zasshi. The japanese journal of urology Jan 1, 2018
A 34-year-old man presented with scrotal pain and slight fever. The scrotal pain was improved by the treatment of antibiotics, but the slight fever remained and an abdominal protuberance appeared. Computed tomography showed a 22 cm abdominal tumor wi...
Humans Adult Male Time Factors Lung Neoplasms Antineoplastic Combined Chemotherapy Protocols Treatment Outcome Lymph Node Excision Pneumonectomy Neoplasm Recurrence, Local Combined Modality Therapy Doxorubicin Surgical Procedures, Operative Etoposide Ifosfamide Liposarcoma Retroperitoneal Neoplasms Thoracoscopy
View on PubMed DOI
Popular Topics
Recent Journals